FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395828009: Pioglitazone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469768013 Pioglitazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489469013 Pioglitazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1469768013 Pioglitazone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1469768013 Pioglitazone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489469013 Pioglitazone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1489469013 Pioglitazone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49941000195117 pioglitazone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
64121000195117 Pioglitazon de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
189791000077113 pioglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
189791000077113 pioglitazone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
49941000195117 pioglitazone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
64121000195117 Pioglitazon de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pioglitazone (substance) Is a agent antidiabétique false Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone (substance) Is a Thiazolidinedione (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone (substance) Has disposition Peroxisome proliferator-activated gamma receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing pioglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone hydrochloride Is a False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing metformin and pioglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing glimepiride and pioglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone 30mg + metformin 1g m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone 15mg + metformin 1g m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet Has basis of strength substance (attribute) False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin hydrochloride 850 mg and pioglitazone (as pioglitazone hydrochloride) 15 mg oral tablet Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Pioglitazone 30mg + metformin 1g prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Pioglitazone 15mg + metformin 1g prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing pioglitazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Metformin- and pioglitazone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Pioglitazone hydrochloride Is modification of (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Glimepiride and pioglitazone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin and pioglitazone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Pioglitazone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Glimepiride and pioglitazone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only pioglitazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only metformin and pioglitazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing alogliptin and pioglitazone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin and pioglitazone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing alogliptin and pioglitazone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin and pioglitazone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet Has basis of strength substance (attribute) True Pioglitazone (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start